Form 4 for OPRX OptimizeRx Corp
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-04 · accession 0001213900-21-051450 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-05 | 2021-10-04 | OPRX | Paramore Miriam J | Pres AND CSO | S - Sale+OE | $84.67 | -15.0K | 74.6K | -17% | -$1.27M |
| D | 2021-10-05 | 2021-10-04 | OPRX | Paramore Miriam J | Pres AND CSO | M - OptEx | $7.51 | +15.0K | 89.6K | +20% | +$112.7K |
| D | 2021-10-05 | 2021-10-04 | OPRX | Paramore Miriam J | Pres AND CSO | M - OptEx | $0.00 | -15.0K | 109.3K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Pursuant to 10B5-1 Plan | 2021-10-04 | S | D | 15,000 | $84.67 | 74,607 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 2 | Common | Common Stock | 2021-10-04 | M | A | 15,000 | $7.51 | 89,607 | D | — | — | |
| 3 | Derivative | Stock Option | 2021-10-04 | M | D | 15,000 | $0.00 | 109,318 | D | $7.51 · 2020-03-31 to 2025-03-11 | 15,000 Common Stock |